Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • BFSI
      • Capital Goods
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Health»Early Surgical Intervention in Parkinson’s Disease: Why Waiting Too Long May Limit Treatment Benefits? – Dr. Naren Nayak
    Health

    Early Surgical Intervention in Parkinson’s Disease: Why Waiting Too Long May Limit Treatment Benefits? – Dr. Naren Nayak

    WebDeskBy WebDeskFebruary 24, 2026No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Thane (Maharashtra) [India], February 24: Patients with Parkinson’s disease require primary medication for their condition until they reach the point where doctors need to conduct surgery. Medical research currently demonstrates that patients with Parkinson’s disease can achieve better long-term results through surgical treatment when they undergo surgery at an early stage of their condition.

    Dr. Naren Nayak, Consultant Neurosurgeon in Thane and Movement Disorder Specialist, states that patients who postpone their medical evaluation until their symptoms become severe will experience lower treatment success with advanced medical solutions which will hinder their progress toward better health. Parkinson’s disease causes patients to develop their condition in stages which results in medications producing “on-off” effects and multiple “on” and “off” symptom periods. People hold a false belief which Dr. Nayak describes as surgical treatment needing to wait until all other methods have shown no success. The early assessment process enables specialists to identify patients who will receive the most benefit from surgical procedures such as Deep Brain Stimulation (DBS) for Parkinson’s disease before their condition reaches a point which will result in less effective outcomes. Parkinson’s disease DBS treatment operates as an established surgical procedure which scientists have researched through medical studies. The treatment enables patients to control their tremors and rigidity along with their movement speed and motor fluctuations by using electrical stimulation to activate brain areas.

    DBS proves effective when provided at correct times because it decreases medication requirements while sustaining daily symptom control and enabling substantial progress in patient independence. Early surgical assessment leads to two outcomes for patients which include assessment of their medical condition through neurological testing and neurosurgical evaluation for determining which treatments should proceed and when based on their medical condition. Modern functional neurosurgery provides patients with targeted treatment options which include DBS, Thalamotomy, Pallidotomy, Radiofrequency Lesioning and MR-Guided Focused Ultrasound (MRgFUS) for specifically selected patients who require movement disorder treatment. The implementation of advanced imaging systems together with precise targeting abilities and modern technological advancements enables procedures to achieve improved safety levels and enhanced operational efficiency compared to previous times.

    Research from around the world shows that patients who get surgery in the early stages of their medical condition experience better results with their motor skills and overall life satisfaction while maintaining higher levels of social and work engagement. The healthcare system needs to draw more attention toward treating disability which happens before patients reach critical impairment because this period provides major advantages which include surgical treatment with higher success rates. Dr. Nayak emphasizes that timely referral is critical, stating that “patients should be evaluated for surgical options when medications start causing side effects or no longer provide consistent control, not years later when options become restricted.”

    Dr. Naren Nayak

    Phone: +91 9820456326

    KIMS Hospitals, Thane, Thane Hiranandani Estate Queens Street, Ghodbunder Rd, opposite BRENTFORD, Patlipada, Thane West, Thane, Maharashtra 400607

    Website: https://drnarennayak.com/

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

    Health
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    WebDesk
    • Website

    Related Posts

    How Oncare Is Building a More Transparent & Affordable Model for Cancer Treatment in India

    September 17, 2026

    A First in India: Dermatologist Dr. Jagdish Sakhiya Launches Exclusive Facial Kit Formulated for Indian Skin

    September 10, 2026

    Six Generations of Medical Legacy Drive Sarkar Superspeciality Hospital’s Expansion in Agra

    September 9, 2026

    Comments are closed.

    Recent Post
    • World’s Largest Women-Only Marathon, The Nagoya Women’s Marathon 2027 opens entries for Indian women
    • The Omega Heist Author Madhav Das Meets Legendary Indian Actor Amitabh Bachchan
    • IMS UCC Ghaziabad Welcomes Freshers with an Inspiring Orientation Day, Marking the Beginning of a New Academic Journey
    • New Girls’ Hostel–1 Inaugurated at RGIPT Sivasagar Campus
    • Raincheck Earth Appoints Prashant Singh as Head of International Business
    • Celewish Media Introduces Maira Vardhan As Its AI Virtual CMO, Bringing AI-Led Thinking To Celebrity & Influencer Marketing
    • Hazoor Multi Projects Secures Rs 207 Crore Work Order for Chennai Residential Project
    • Sarvajanik University Hosts Youth Conclave on Climate Resilience and Sustainable City

    Type above and press Enter to search. Press Esc to cancel.